Moneycontrol PRO
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now

Aarti Drugs Consolidated March 2022 Net Sales at Rs 694.27 crore, up 38.37% Y-o-Y

May 09, 2022 / 09:17 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Reported Consolidated quarterly numbers for Aarti Drugs are:

Net Sales at Rs 694.27 crore in March 2022 up 38.37% from Rs. 501.75 crore in March 2021.

Quarterly Net Profit at Rs. 55.32 crore in March 2022 up 7.11% from Rs. 51.65 crore in March 2021.

EBITDA stands at Rs. 88.96 crore in March 2022 up 8.62% from Rs. 81.90 crore in March 2021.

Aarti Drugs EPS has increased to Rs. 5.97 in March 2022 from Rs. 5.54 in March 2021.

Aarti Drugs shares closed at 445.75 on May 06, 2022 (NSE) and has given -20.68% returns over the last 6 months and -45.21% over the last 12 months.

Aarti Drugs
Consolidated Quarterly Resultsin Rs. Cr.
Mar'22Dec'21Mar'21
Net Sales/Income from operations694.27634.80501.75
Other Operating Income------
Total Income From Operations694.27634.80501.75
EXPENDITURE
Consumption of Raw Materials471.08416.80301.35
Purchase of Traded Goods23.7921.5226.59
Increase/Decrease in Stocks-17.23-18.89-8.35
Power & Fuel------
Employees Cost21.5320.9119.93
Depreciation12.5512.6012.28
Excise Duty------
Admin. And Selling Expenses------
R & D Expenses------
Provisions And Contingencies------
Exp. Capitalised------
Other Expenses109.10104.4681.30
P/L Before Other Inc., Int., Excpt. Items & Tax73.4577.4068.65
Other Income2.966.660.97
P/L Before Int., Excpt. Items & Tax76.4184.0669.62
Interest5.915.374.37
P/L Before Exceptional Items & Tax70.5078.6965.25
Exceptional Items------
P/L Before Tax70.5078.6965.25
Tax15.1820.4113.60
P/L After Tax from Ordinary Activities55.3258.2851.65
Prior Year Adjustments------
Extra Ordinary Items------
Net Profit/(Loss) For the Period55.3258.2851.65
Minority Interest------
Share Of P/L Of Associates------
Net P/L After M.I & Associates55.3258.2851.65
Equity Share Capital92.6092.6093.20
Reserves Excluding Revaluation Reserves------
Equity Dividend Rate (%)------
EPS Before Extra Ordinary
Basic EPS5.976.295.54
Diluted EPS5.976.295.54
EPS After Extra Ordinary
Basic EPS5.976.295.54
Diluted EPS5.976.295.54
Public Share Holding
No Of Shares (Crores)------
Share Holding (%)------
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
b) Non-encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
Source : Dion Global Solutions Limited

first published: May 9, 2022 09:11 pm